Skip to content

The effectiveness of cryotherapy in reducing excess weight and obesity

The effect of systemic cryotherapy treatments on selected skin characteristics and the profile of selected adipokines and sirtuins in middle-aged people with varying degrees of body fat

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000168358
Enrollment
23
Registered
2026-02-10
Start date
2024-04-15
Completion date
2024-05-06
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study aimed to evaluate the effectiveness of cryotherapy in reducing overweight and obesity. The effect of cryogenic temperatures on adipose tissue hormones, carbohydrate metabolism, sirtuin activity, and selected skin characteristics was examined. The volunteers were divided into a study group (BMI >27) and a control group (BMI 18.5-25) and underwent a series of 20 whole-body cryotherapy treatments. Blood samples taken from volunteers (before the start of the treatment series, before the 10th and 20th cryotherapy treatments, and 2 weeks after the end of the treatment series) were used to measure the following: adipose tissue hormones, carbohydrate metabolism, and sirtuin activity. In addition, the volunteers' weight and waist and hip circumferences were measured at the same time points. Selected skin characteristics were examined before and after the 1st, 10th, and 20th whole-body cryotherapy treatment.

Interventions

Study volunteers were grouped according to the indicated criteria in a study group (SG) with a BMI (body mass index) above 27 and a control group (CG) with a BMI within the normal range (18–25). A medical consultation was conducted for each participant prior to the study. The study included a series of 20 Whole Body Cryotherapy (WBC) treatments held daily (4 weeks excluding Saturdays and Sundays). Each participant signed the attendance list before entering the keiokomora. Participants were allo

Study volunteers were grouped according to the indicated criteria in a study group (SG) with a BMI (body mass index) above 27 and a control group (CG) with a BMI within the normal range (18–25). A medical consultation was conducted for each participant prior to the study. The study included a series of 20 Whole Body Cryotherapy (WBC) treatments held daily (4 weeks excluding Saturdays and Sundays). Each participant signed the attendance list before entering the keiokomora. Participants were allowed to miss one cryotherapy treatment; multiple absences resulted in exclusion from the study. Body composition measurements and blood samples were taken before the 1st, 10th and 20th WBC treatments, and 2 weeks after cessation of cryostimulation. Selected skin parameters were measured immediately before and after the 1st, 10th, and 20th WBC sessions at two locations: on the face near the zygomatic bone and on the inside of the forearm. It was assumed that the survey would be conducted on the dominant hand. Preparation for the procedure followed standard protocols. Before entering the cryochamber, volunteers were asked to remove jewelry and glasses and to dress in appropriate attire: a cap, a mask covering the nose and mouth, a bathing suit/shorts, gloves, gaiters or long socks covering the tibias and knee joints, and clogs with thick soles. Each WBC procedure included a 30 s acclimatization in the cryochamber atrium (-60 °C), followed by a 3 min treatment in the cryochamber proper (-120 °C). Volunteers walked in a single file, changing direction every 30 s. They exited the cryochamber through its atrium. Immediately after exiting, participants underwent skin characteristics measurements and, in turn, were directed to the training room, where they performed aerobic exercises. Each treatment took place under the supervision of a specialist who monitored its progress through a window built into the cryochamber. Participants were informed that they could leave the cryochamber early if they experienced discomfort. Body height was measured once using a Seca 216 growth meter (Germany, Ham-burg), with an accuracy of 5 mm. Body weight was measured with a JAWON MEDICAL IOI-353-CE0197 scale (Jawon Medical Co., Ltd., Gyeongsan, Republic of Korea) using the bioimpedance method. In addition, BMI was calculated for each subject. Skin parameters were measured according to the protocol of the Skin Physiology Laboratory (CLNB) of the AKF in Krakow (Academy of Physical Culture in Krakow, certificate number PN-EN ISO 9001:2015: PW-08606-19). Measurements were performed on healthy, undamaged skin. The Multi Probe Adapter (MPA) System (Courage-Khazaka GmBH, Cologne, Germany) was used. The set included measuring probes from the same manufacturer: (1) Corneometer CM 825 (measurement error: ± 3%); (2) Tewameter TM 300 (measurement error: water loss: ± 0.5 g/h/m2 for RH = 30%; ±1.0 g/hm2 for RH = 30%); (3) Skin-pH-Meter PH 905 (error: ± 0.1); and (4) Cutometer Dual MPA 580. Due to the storage of the pH measurement electrode in potassium chloride aqueous solution, the skin pH measurement was made last in the series of measurements so as not to disturb the measurement results of other parameters. A 1-second measurement method was used for the corneometric and pH-metric measurements and a continuous (20 s) method for the tewametric measurements. The cutometer test included a suction phase (the skin was suctioned with a vacuum for 3 s) and a 3 s relaxation phase. All measurements were taken at a given location three times, and the arithmetic mean of the results was calculated.

Sponsors

University of Physical Culture, 31-571 Krakow, Poland
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

The inclusion criteria considered in the process of qualifying participants for the project were BMI > 27 for the study group; BMI 18.5–25 for the control group; not taking winter baths, and no use of systematic cryotherapy at least 6 months prior; written consent for voluntary participation in the study; and consent of the qualifying physician.

Exclusion criteria

The exclusion criteria were chronic endocrine and dermatological diseases; skin conditions of fungal, bacterial, or viral origin; health problems (neurological or orthopedic) that prevent independent movement; taking anti-inflammatory medications and supplements con-taining vitamins and antioxidants; and lack of consent to participate in the study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 19, 2026